Peijia Medical Limited
PEJMF
$1.39
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 85.57M | 78.70M | 71.68M | 66.93M | 62.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.57M | 78.70M | 71.68M | 66.93M | 62.38M |
| Cost of Revenue | 25.29M | 22.79M | 20.25M | 18.27M | 16.33M |
| Gross Profit | 60.28M | 55.91M | 51.43M | 48.66M | 46.06M |
| SG&A Expenses | 66.67M | 64.31M | 61.81M | 63.75M | 65.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.67M | -3.27M | -3.85M | -3.30M | -2.74M |
| Total Operating Expenses | 117.56M | 113.41M | 109.02M | 108.55M | 108.49M |
| Operating Income | -31.99M | -34.71M | -37.35M | -41.63M | -46.10M |
| Income Before Tax | -30.84M | -32.66M | -34.39M | -44.75M | -55.44M |
| Income Tax Expenses | 958.50K | 705.60K | 451.20K | 300.60K | 149.30K |
| Earnings from Continuing Operations | -31.79 | -33.36 | -34.84 | -45.05 | -55.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 267.00K | 135.50K | 3.40K | 3.70K | 4.00K |
| Net Income | -31.53M | -33.23M | -34.84M | -45.05M | -55.58M |
| EBIT | -31.99M | -34.71M | -37.35M | -41.63M | -46.10M |
| EBITDA | -24.57M | -28.18M | -31.73M | -36.21M | -40.88M |
| EPS Basic | -0.05 | -0.05 | -0.05 | -0.07 | -0.08 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 |
| EPS Diluted | -0.05 | -0.05 | -0.05 | -0.07 | -0.08 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 2.68B | 2.70B | 2.72B | 2.72B | 2.72B |
| Average Diluted Shares Outstanding | 2.68B | 2.70B | 2.72B | 2.72B | 2.72B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |